Cargando…

Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor–free, Belatacept Plus Everolimus–based Immunosuppression

Compared with calcineurin inhibitor–based immunosuppression, belatacept (BELA)-based treatment has been associated with better renal function but higher acute rejection rates. This phase 2 study (NCT02137239) compared the antirejection efficacy of BELA plus everolimus (EVL) with tacrolimus (TAC) plu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peddi, V. Ram, Marder, Bradley, Gaite, Luis, Oberholzer, Jose, Goldberg, Ryan, Pearson, Thomas, Yang, Harold, Allamassey, Lisa, Polinsky, Martin, Formica, Richard N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Kidney Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820789/ https://www.ncbi.nlm.nih.gov/pubmed/36700062 http://dx.doi.org/10.1097/TXD.0000000000001419

Ejemplares similares

Late Conversion From Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic Parameters
por: Terrec, Florian, et al.
Publicado: (2019)

Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients
por: Tedesco-Silva, Helio, et al.
Publicado: (2016)

Belatacept Conversion in Kidney After Liver Transplantation
por: Cristea, Octav, et al.
Publicado: (2021)

Improved Glucose Tolerance in a Kidney Transplant Recipient With Type 2 Diabetes Mellitus After Switching From Tacrolimus To Belatacept: A Case Report and Review of Potential Mechanisms
por: de Graav, Gretchen N., et al.
Publicado: (2018)

Three-year Outcomes After Conversion From Monthly to Every 2-month Belatacept Maintenance Therapy in Kidney Transplant Recipients: Results From a Randomized Controlled Trial
por: Johnson, Aileen C., et al.
Publicado: (2023)

Immunomics of Renal Allograft Acute T Cell-Mediated Rejection Biopsies of Tacrolimus- and Belatacept-Treated Patients
por: van der Zwan, Marieke, et al.
Publicado: (2018)

One-year Outcome of Everolimus With Standard-dose Tacrolimus Immunosuppression in De Novo ABO-incompatible Living Donor Kidney Transplantation: A Retrospective, Single-center, Propensity Score Matching Comparison With Mycophenolate in 42 Transplants
por: Noguchi, Hiroshi, et al.
Publicado: (2019)

Long-term Prolonged-release Tacrolimus-based Immunosuppression in De Novo Kidney Transplant Recipients: 5-Y Prospective Follow-up of Patients in the ADVANCE Study
por: Pernin, Vincent, et al.
Publicado: (2023)

Reliability and Validity of the Japanese Version of the Basel Assessment of Adherence to Immunosuppressive Medications Scale in Kidney Transplant Recipients
por: Kosoku, Akihiro, et al.
Publicado: (2023)

De Novo Belatacept in a Kidney-After-Heart Transplant Recipient
por: Schenk, Austin D., et al.
Publicado: (2019)

Application of Operational Tolerance Signatures Are Limited by Variability and Type of Immunosuppression in Renal Transplant Recipients: A Cross-Sectional Study
por: Bottomley, Matthew J., et al.
Publicado: (2016)

High Calcineurin Inhibitor Intrapatient Variability Is Associated With Renal Allograft Inflammation, Chronicity, and Graft Loss
por: Sharma, Akhil, et al.
Publicado: (2019)

The Privilege of Induction Avoidance and Calcineurin Inhibitors Withdrawal in 2 Haplotype HLA Matched White Kidney Transplantation
por: Brifkani, Zaid, et al.
Publicado: (2017)

mTOR Inhibition by Everolimus Does Not Impair Closure of Punch Biopsy Wounds in Renal Transplant Patients
por: Dutt, Shelley B., et al.
Publicado: (2017)

Comparison of the Immune Response After an Extended Primary Series of COVID-19 Vaccination in Kidney Transplant Recipients Receiving Standard Versus Mycophenolic Acid–sparing Immunosuppressive Regimen
por: Phirom, Supitchaya, et al.
Publicado: (2022)

Effect of Early Steroid Withdrawal on Posttransplant Diabetes Among Kidney Transplant Recipients Differs by Recipient Age
por: Ahn, JiYoon B., et al.
Publicado: (2021)

Effect of Maintaining Immunosuppression After Kidney Allograft Failure on Mortality and Retransplantation
por: Balakrishnan, Suryanarayanan, et al.
Publicado: (2022)

Long-term Immunosuppression Adherence After Kidney Transplant and Relationship to Allograft Histology
por: Lorenz, Elizabeth C., et al.
Publicado: (2018)

Acute Rejection Phenotypes in the Current Era of Immunosuppression: A Single-Center Analysis
por: Wehmeier, Caroline, et al.
Publicado: (2017)

Atherosclerosis and Intrarenal Resistance Index in Kidney Transplant Recipients
por: Bloemendal, Niels T., et al.
Publicado: (2023)

En Bloc Cadaver Kidney Transplantation From a 9-Month-Old Donor to an Adult Recipient: Maturation of Glomerular Size and Podocyte in the Recipient
por: Hirukawa, Takashi, et al.
Publicado: (2017)

Kidney Transplantation From Hepatitis C Viremic Deceased Donors to Aviremic Recipients in a Real-world Setting
por: Concepcion, Beatrice P., et al.
Publicado: (2021)

The Influence of Donor to Recipient Size Matching on Kidney Transplant Outcomes
por: Arshad, Adam, et al.
Publicado: (2018)

The Evolution of Monoclonal Gammopathy of Undetermined Significance in Kidney Transplant Recipients
por: Gagnon, Marie-France, et al.
Publicado: (2019)

Perspectives of Kidney Transplant Recipients on eHealth: Semistructured Interviews
por: Tang, James, et al.
Publicado: (2022)

The Impact of Withdrawal of Maintenance Immunosuppression and Graft Nephrectomy on HLA Sensitization and Calculated Chance of Future Transplant
por: Nimmo, Ailish M. S. A., et al.
Publicado: (2018)

Celiac-like Enteropathy Associated With Mycophenolate Sodium in Renal Transplant Recipients
por: Filiopoulos, Vassilis, et al.
Publicado: (2018)

Effect of Sodium Bicarbonate in Kidney Transplant Recipients With Chronic Metabolic Acidosis
por: Schulte, Kevin, et al.
Publicado: (2019)

Plasma Proenkephalin and Poor Long-Term Outcome in Renal Transplant Recipients
por: Kieneker, Lyanne M., et al.
Publicado: (2017)

Liver Enzymes and the Development of Posttransplantation Diabetes Mellitus in Renal Transplant Recipients
por: Klaassen, Gerald, et al.
Publicado: (2017)

Differences in Gene Expression in Older Compared With Younger Kidney Transplant Recipients
por: Schaenman, Joanna M., et al.
Publicado: (2019)

Blood Pressure Treatment in Kidney Transplant Recipients—Can We Improve?
por: Onsøien, Mari O., et al.
Publicado: (2021)

The Risk of Postkidney Transplant Outcomes by Induction Choice Differs by Recipient Age
por: Ahn, JiYoon B., et al.
Publicado: (2021)

Endothelial Dysfunction and 6-Year Risk of Mortality in Kidney Transplant Recipients
por: Langberg, Nina Elisabeth, et al.
Publicado: (2021)

An Unusual Cause of Hepatitis With Nephrotic Syndrome in a Kidney Transplant Recipient
por: Chan, Koon Ming, et al.
Publicado: (2022)

Alloreactive T cells to Assess Acute Rejection Risk in Kidney Transplant Recipients
por: Mendoza Rojas, Aleixandra, et al.
Publicado: (2023)

Graft Growth and Podocyte Dedifferentiation in Donor-Recipient Size Mismatch Kidney Transplants
por: Müller-Deile, Janina, et al.
Publicado: (2017)

Sirolimus Increases T-Cell Abundance in the Sun Exposed Skin of Kidney Transplant Recipients
por: Burke, Michael Thomas, et al.
Publicado: (2017)

Financial Evaluation of Kidney Transplant With Hepatitis C Viremic Donors to Uninfected Recipients
por: Axelrod, David A., et al.
Publicado: (2020)

Predictors of Nonseroconversion to SARS-CoV-2 Vaccination in Kidney Transplant Recipients
por: Frölke, Sophie C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hsqoofmv4630rcvia2pvfhsd9h